Search results

Filter (5 in use)

Type 3 selected

  • Remove filter for Guidance (2)
  • Remove filter for Research recommendations
  • Remove filter for Quality standards

Status 1 selected

  • Filter by Published (504)
  • Filter by In development (478)
  • Filter by Proposed (118)
  • Remove filter for In consultation (2)

Last updated

  • Filter by Last 3 months
  • Filter by Last 6 months
  • Filter by Last year
  • Filter by Last 3 years

Guidance programme 1 selected

  • Filter by NICE guidelines (4)
  • Remove filter for Technology appraisal guidance (2)

2 results

Sorted by Relevance . | Sort by Date

  • Guidance Remove Guidance filter
  • Research recommendations Remove Research recommendations filter
  • Quality standards Remove Quality standards filter
  • In consultation Remove In consultation filter
  • Technology appraisal guidance Remove Technology appraisal guidance filter
  1. Anakinra for treating active Stills disease [ID1463]: appraisal consultation

    We are listening to your views on this technology appraisal guidance. Comments close 27 January 2021.

    Type
    Technology appraisal guidance
    Status
    In consultation
  2. Nivolumab for treating squamous cell carcinoma of the head and neck after platinum-based chemotherapy (CDF Review TA490) [ID1585]: appraisal consultation

    We are listening to your views on this technology appraisal guidance. Comments close 28 January 2021.

    Type
    Technology appraisal guidance
    Status
    In consultation